Passage Bio Inc. (NASDAQ: PASG)
$0.95
+0.0288 ( +3.13% ) 1.4M
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Market Data
Open
$0.95
Previous close
$0.92
Volume
1.4M
Market cap
$58.63M
Day range
$0.87 - $1.12
52 week range
$0.58 - $1.79
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 41 | Aug 07, 2023 |
| 10-q | Quarterly Reports | 61 | Aug 07, 2023 |
| 4 | Insider transactions | 1 | Aug 01, 2023 |
| 8-k | 8K-related | 12 | Jul 31, 2023 |
| 3 | Insider transactions | 2 | Jul 31, 2023 |
| 4 | Insider transactions | 1 | Jul 31, 2023 |
| 3 | Insider transactions | 2 | Jul 28, 2023 |
| 4 | Insider transactions | 1 | Jul 28, 2023 |
| 8-k | 8K-related | 12 | Jul 20, 2023 |